Zhejiang Huahai Pharmaceuticals Co Ltd stock dropped in early trades on October 8 as the FDA blocked all imports of drug ingredients or medicines made by the company as reported by Epoch Times.  The makers of Valsartan (blood pressure treatment), recalled the product...